Printer Friendly

Chantal elects new board member.

LOS ANGELES--(BUSINESS WIRE)--June 6, 1996--Chantal Pharmaceutical Corporation (NASDAQ:CHTL) today announced that Norman F. Estrin, Ph.D., RAC, a 25-year veteran of the cosmetic industry, has been elected to the company's board of directors.

The announcement was made by Chantal Burnison, chairman and chief executive officer.

This is the first in a series of steps that the company is taking to strengthen both its board and management, said Ms. Burnison. "Dr. Estrin's extensive experience, both domestically and internationally, and superb qualifications will be particularly valuable as the Company expands the marketing and distribution of its Ethocyn-based cosmetic products into the global marketplace," she said. Dr. Estrin has already been working with and will continue to serve as a consultant to the company, specifically with respect to the company's product launched into the Pacific Rim and other worldwide markets.

Dr. Estrin assists pharmaceutical, cosmetic and other companies in executing international marketing and distribution programs, including structuring and negotiating licensing and distribution arrangements, and in complying with FDA and other government regulatory requirements, including regulatory submissions. In addition, he serves as a consultant to government agencies, medical conference planning organizations and an international marketing management company. Dr. Estrin conceived, developed and edited several internationally recognized text books in the cosmetic industry, and is currently editing a new book, Cosmetic Regulation in a Competitive Environment.

Dr. Estrin brings to Chantal Pharmaceutical extensive expertise in the cosmetic industry, having held several management positions, including Senior Vice President-Science, at The Cosmetic, Toiletry and Fragrance Association from 1968 through 1985. While at CTFA, he created and edited the Cosmetic Ingredient Dictionary, which is recognized by the Food and Drug Administration and internationally as the official compendium for ingredient labeling.

Dr. Estrin left CFTA in 1985 to assume the position of Vice President - Science and Technology at the Health Industry Manufacturers Association, where he developed a number of international and domestic programs relating to the medical device industry.

Dr. Estrin also has served as a consultant to the National Cancer Institute, a research assistant at Florida State University in Tallahassee, Fla., and as a chemist at Clairol Research Laboratories in Stamford, Conn.

He received his doctorate in Physical-Organic Chemistry from Florida State University and is Regulatory Affairs Certified (RAC) by the Regulatory Affairs Professional Society. He serves on the board of The National Museum for Health & Medicine Foundation, The Institute for Advancement of Medical Communication and Discovery Pharmaceuticals, Inc., a company he co-founded in 1990. Dr. Estrin is a member of the Editorial Advisory Boards of the Medical Device Approval Letter and The Validation Consultant.

Chantal Pharmaceutical Corporation has executive offices, telemarketing and warehouse facilities in Los Angeles, with a laboratory in Kaiserslautern, Germany. In addition to marketing the Chantal Ethocyn Skin Care Line, the company is engaged in the research and development of androgen mediated disorders such as acne, hirsutism, male pattern baldness, benign prostate hypertrophy and the treatment of certain cancers.

CONTACT: Martin E. Janis & Company, Inc.

Bev Jedynak, 312/943-1100
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 6, 1996
Words:498
Previous Article:A New Writing Program For A New Generation Of Students Released By Prentice Hall School Division.
Next Article:Triden Telecom Inc. Hires new COO, Signs Letter of Intent, Increases Revenues by $1.5 Million.
Topics:


Related Articles
TEEN ARTISTS DO THEIR PART FOR THE NEEDY.
THRILL ISN'T GONE FOR FAIRGOERS.
BIZWATCH : MARKETS.
BIZWATCH : MARKETS.
CHANTAL FIGHTS TO REGAIN CONFIDENCE OF INVESTORS.
Council ousts city's embattled manager.
RWYouth.com: through the Internet, RWYouth is bringing together young Americans to learn more about their priceless heritage of liberty.
JUST KICKIN' IT IN THE VALLEY TEENS KARATE CHOP THEIR WAY TO MENTAL, PHYSICAL STRENGTH.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters